Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples